Tiếp theo

Tự chạy

Zev Wainberg, MD, considers regorafenib in locally advanced biliary tract cancer

6 Lượt xem • 07/09/23
Đăng lại
Nhúng
administrator
administrator
Người đăng ký
0

Dr. Wainberg, Co-Director, UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Cancer Center, Assistant Professor of Medicine, Division of Hematology Oncology, David Geffen School of Medicine at UCLA, considers the Phase 2 REACHIN study investigating regorafenib in locally advanced biliary tract cancer

Cho xem nhiều hơn
0 Bình luận sort Sắp xếp theo
Bình luận trên Facebook

Tiếp theo

Tự chạy